Daniel L Kisner's Net Worth

$387 Thousand

Estimate Recalculated Nov 1, 2024 05:35AM EST

Who is Daniel L Kisner?

Daniel L Kisner does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DYNAVAX TECHNOLOGIES CORP, TEKMIRA PHARMACEUTICALS CORP, LPATH, INC, Oncternal Therapeutics, Inc., Conatus Pharmaceuticals Inc., Zynerba Pharmaceuticals, Inc., CALIPER LIFE SCIENCES INC, and SEQUENOM INC.

SEC CIK

Daniel L Kisner's CIK is 0001073407

Past Insider Trading and Trends

2008 was Daniel L Kisner's most active year for acquiring shares with 13 total transactions. Daniel L Kisner's most active month to acquire stocks was the month of April. 2008 was Daniel L Kisner's most active year for disposing of shares, totalling 92 transactions. Daniel L Kisner's most active month to dispose stocks was the month of April. 2005 saw Daniel L Kisner paying a total of $97,300.00 for 14,000 shares, this is the most they've acquired in one year. In 2008 Daniel L Kisner cashed out on 153,000 shares for a total of $272,709.73, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $10.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+43.86%
5.36K
—
—
17.57K
May 23
Form 4
+78.12%
5.36K
—
—
12.21K
May 26
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Oct 13
Form 4
—
0
—
—
0
May 27
Form 4
—
0
—
—
0
May 28
Form 4
+200.00%
10K
$1.08
$10,750.00
15K
Oct 30
Form 4
—
0
—
—
0
May 29
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
Mar 9
Form 4
∞
5K
$2.02
$10,100.00
5K
Jan 26
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jul 22
Form 3
—
0
—
—
0
No matching records found

TEKMIRA PHARMACEUTICALS CORP (ABUS) Snapshot price: $4.5488

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

LPATH, INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Feb 16
Form 4
—
0
—
—
0
Feb 10
Form 4
—
0
—
—
0
Feb 10
Form 4
—
0
—
—
0
Jan 29
Form 4
∞
70.59K
—
—
70.59K
Jul 30
Form 3
—
0
—
—
0
No matching records found

Oncternal Therapeutics, Inc. (ONCT) Snapshot price: $4.47

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
May 25
Form 4/A
—
0
—
—
0
Jun 11
Form 4/A
—
0
—
—
0
Sep 12
Form 4
∞
10K
$2.38
$23,825.00
10K
Jul 21
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Sep 12
Form 3
—
0
—
—
0
No matching records found

Conatus Pharmaceuticals Inc. (HSTO) Snapshot price: $0.2225

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 1
Form 4/A
∞
3.15K
—
—
3.15K
Feb 19
Form 3
—
0
—
—
0
No matching records found